Primary objectives
• To determine whether molecularly targeted therapies, in addition to surgery and/or chemotherapy and/or radiotherapy for oral cavity or oropharyngeal cancers result in increased overall survival, disease free survival, progression free survival, locoregional control and reduced recurrence.